Home > Healthcare > Pharmaceuticals > Disease Specific Drugs > Tacrolimus Market

Tacrolimus Market Share

  • Report ID: GMI8362
  • Published Date: Mar 2024
  • Report Format: PDF

Tacrolimus Market Share

The tacrolimus industry is competitive in nature, with several large multinationals and small and mid-sized companies competing in the industry. The development and launch of novel advanced products based on different formulations is among a key market strategy. Some of the leading industry players including Abbott Laboratories, Astellas Pharma Inc., Novartis AG, Biocon Ltd., and Glenmark Pharmaceuticals Ltd. among others have a notable presence in the market.

 

Tacrolimus Market Companies

Some of the eminent market participants operating in the tacrolimus industry include:

  • Abbott Laboratories
  • Astellas Pharma Inc.
  • Biocon Ltd.
  • F. Hoffmann-La Roche Ltd
  • Glenmark Pharmaceuticals Ltd.
  • GSK plc
  • Lupin Pharmaceuticals Ltd
  • Novartis
  • Pfizer Inc.
  • Takeda Pharmaceutical Company Limited
  • Viatris Inc.
Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The market size of tacrolimus reached USD 6.6 billion in revenue in 2023 and is set to witness 5.6% CAGR from 2024 to 2032, led by the rising number of organ transplant procedures and the increasing prevalence of autoimmune diseases.

The injections segment is estimated to account for USD 4.1 billion in revenue by 2032, owing to their increasing use in the critical post-operative period to ensure timely and effective immunosuppression, particularly in patients that are unable to tolerate oral medications.

North America market size was valued at USD 2.7 billion in 2023, owing to the presence of advanced healthcare infrastructure, including specialized transplant centers, hospitals, and clinics equipped to perform organ transplant surgeries.

Some of the top companies engaged in the industry are Abbott Laboratories, Astellas Pharma Inc., Biocon Ltd., F. Hoffmann-La Roche Ltd, Glenmark Pharmaceuticals Ltd., GSK plc, Lupin Pharmaceuticals Ltd, Novartis, Pfizer Inc., Takeda Pharmaceutical Company Limited, and Viatris Inc.

Tacrolimus Market Scope

Buy Now


Premium Report Details

  • Base Year: 2023
  • Companies covered: 11
  • Tables & Figures: 188
  • Countries covered: 22
  • Pages: 110
 Download Free Sample